ACTRN12622000519752
Not Yet Recruiting
N/A
nderstanding rheumatoid arthritis sufferers motivations and intentions towards exercise prior and post undertaking a five week exercise trial.
Queensland University Technology0 sites30 target enrollmentApril 1, 2022
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis
- Sponsor
- Queensland University Technology
- Enrollment
- 30
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) \>18 years of age and 2\) RA stable with no changes in medication in the last 2 months (small changes up to 5 mg in prednisone are allowed) and 3\) located within the Brisbane metropolitan area for access to the Queensland University Technology health clinics and 4\) English speaking. All participants will consult with their general medical practitioner prior to inclusion to confirm diagnosis and safety to participate.
Exclusion Criteria
- •1\) already undertaking \>2 days a week of regular moderate intensity exercise training; 2\) no other underlying uncontrolled medical conditions that may limit their participation in an exercise program for example including heart disease (heart failure, clinically significant coronary stenosis and previous myocardial infarction), all forms of cancer (both remission and ongoing), knee and hip replacement, and metabolic disease (Type I and II diabetes) and 3\) commencement of a new synthetic disease\- or biological modifying drug
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Efficacy and safety of intra-articular steroid injection for inflamed atlantoaxial joint in patients with rheumatoid arthritisatlantoaxial joint arthritis in rheumatoid patientsInflammatory and Immune System - Rheumatoid arthritisACTRN12616000750482Diab Fuad Hetta60
Active, Not Recruiting
Phase 1
Patients with rheumatoid arthritis and synovitis treated with ultrasound guided intraarticular or intramuscular glucocorticoid injection - A randomised, double-blind, controlled study (Panguian)Treatment of synovitis among rheumatoid arthritis patientsMedDRA version: 21.0Level: PTClassification code 10042868Term: SynovitisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2017-003425-15-DKVidencenter for Reumatologi og Rygsygdomme, Rigshospitalet100
Completed
N/A
Retention rate of iguratimod with and without methotrexate in patients with rheumatoid arthritis.JPRN-UMIN000041767Department of Hematology and Rheumatology, Kindai University School of Medicine106
Not Yet Recruiting
N/A
Mannose-binding lectin (MBL) deficiency is more frequent in rheumatoid arthritis patients with coexistant bronchiectasis than in patients with rheumatoid arthritis alone or bronchiectasis alone.Rheumatoid arthritisBronchiectasisInflammatory and Immune System - Rheumatoid arthritisRespiratory - Other respiratory disorders / diseasesACTRN12611000877987Krista Makin150
Recruiting
N/A
Rheumatoid Arthritis Patients rePort Onset Reactivatioarthritisrheumatoid arthritis10023213NL-OMON30946Erasmus MC, Universitair Medisch Centrum Rotterdam150